Table 3 Mean, ± Sd and range of patient demographic data in thyroid cancer by using Iodine-131.
From: Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia
Gender | Administered activity (MBq) | Dose rate 1st day (µSv/h) | Dose rate 2nd day (µSv/h) | Dose rate, 3rd day (µSv/h) | |||||
|---|---|---|---|---|---|---|---|---|---|
30 cm | 100 cm | 300 cm | Behind bed shield | 30 cm | 100 cm | 30 cm | 100 cm | ||
Male | 4503.0 ± 2046.6 (1825.5–8066.0) | 598 ± 309 (150–1380) | 114 ± 56 (25–230) | 4 ± 2 (0.1–13) | 4 ± 2 (0.1–9) | 204 ± 86 (65–380) | 56 ± 28 (12–137) | 77 ± 46 (0.0–180) | (15 ± 6) (0.0–25) |
Female | 3984.3 ± 1996.2 (1512.2–8066.0) | 499 ± 311 (100–1370) | (99 ± 53) (25–240) | 4 ± 2 (0.1–12) | 4 ± 2 (0.3–12) | 165 ± 82 (35–640) | 41 ± 23 (11–150) | 51 ± 33 (6–150) | 11 ± 5 (1–30) |
Total | 4243.7 ± 2021.4 (1512.2–8066.0) | 5490 ± 3150 (1250–1380) | (107 ± 5.5) (25–240) | 40 ± 20 (0.1–13) | 4 ± 2 (0.1–12) | 185 ± 84 (50–640) | 49 ± 26 (11–150) | 64 ± 39 (0–180) | 13 ± 5.5 (0.0–30) |
